Dr. Wang Chong MBBS, MBA, ASI (42) – Portfolio Manager of Sturgeon Ventures. Prior to joining Sturgeon Ventures, Dr. Wang Chong’s career comprises over 19 years spent in the healthcare industry. He also has significant capital markets experience including raising funds for and listing small to medium size companies in the UK; he has been instrumental in raising over £60 million for small cap companies in the last six years and was previously the Life Sciences Analyst at Canaccord Capital (Europe) Ltd, the multinational investment bank. In the healthcare industry, previous positions include CFO and Commercial Director of Phytopharm plc, a leading botanical pharmaceutical and nutraceutical company, CEO of Osmetech plc, a medical diagnostics company, Leader of UK Healthcare Initiatives at Arthur D. Little Inc, the management consultancy firm, commercial roles at Glaxo Wellcome plc and SmithKline Beecham plc, and an endocrinologist in the National Health Service. Wang combines his analytical and business development expertise with his operational and medical background to achieve results. Dr. Chong graduated with a medical degree from King’s College London and an MBA from London Business School. Wang is a Council Member of the Royal Society of Medicine’s Pharmaceutical Medicine & Research Section and an Associate of the Securities and Investment Institute. Full CV available on request